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Josef NeuAbstract
Background: Early life interactions between the human host and microbes set the stage for future health and disease.
Findings: In this review, some of the relationship of the human microbiome effects will be discussed as they relate
to preterm delivery, early life diseases seen in prematurely delivered infants, and other childhood and adult maladies
which include autoimmunity, allergic diseases, obesity or a healthy phenotype.
Conclusion: Although the data in these areas is just beginning to emerge, this review will provide a brief
summary of some of the key research being done and will also speculate on emerging areas where major
questions are being raised.
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At no stage of a human’s lifetime is the interaction be-
tween microbes and the host as precarious as during
fetal life, infancy and early childhood where critical win-
dows exist for later life programming, which will dictate
the subsequent health of the individual. It is becoming
clear that such programming is not solely dependent on
the nucleotide base pairing sequence of the human gen-
ome, which is composed of only approximately 23,000
genes. Our microbiome, termed by some the “second
genome”, comprises a vastly larger number of cells and
genes than those derived from the human gametes.
Microbes comprising this biome divide rapidly, and have a
great potential for environmentally induced alteration. Fur-
thermore, these microbes, most of which are symbionts
and commensals are now recognized to exert major im-
munologic and metabolic effects on the human host.The in-utero microbiome
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unless otherwise stated.[1]. It is been known for over 30 years that even without a
ruptured amniotic sac, amniotic fluid frequently contains
significant levels of bacteria [2]. Intrauterine “infection”
and a subsequent fetal inflammatory response has been
linked to prematurity, brain, lung and eye disease after
preterm birth [3,4]. Studies in the past decade using non-
culture based techniques further reveal a significant pres-
ence of microbes in placenta, amniotic fluid and meco-
nium [5-9]. These microbes appear to differ depending on
the stage of fetal maturity [5,7]. Since preterm delivery is
often associated with an inflammatory response, the find-
ing that greater degree of prematurity is directly related to
the bacterial DNA load in amniotic fluid suggests a rela-
tionship [6,10]. Causality in this relationship is further
supported by the presence of microbes directly correlated
with increased levels of white blood cells and interleukin-6
(IL-6) in the amniotic fluid, suggesting a pathophysiologic
sequence of increased microbial load, inflammation and
preterm birth [10]. A similar study also showed that diffi-
cult to culture microbial taxa are present in amniotic fluid
and this related to higher levels of IL-6, chorioamnionitis,
funisitis and early onset sepsis [9].
Although it has been known that the placenta fre-
quently harbors microbes, and that these microbes are
associated with prematurity, recent studies using DNA
sequencing to interrogate the placental microbiota fromn Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Morbidities related to preterm birth also relate to
prenatal dysbiosis. The fetal immune system and inflammatory
responses are rapidly evolving before birth. The microbial environment
may enhance or blunt immune and inflammatory responses.
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formed [5]. A relationship between different taxa of mi-
crobes and level of prematurity as well as infections
early in pregnancy were found. Intriguingly a similarity
between placental microbes and those found in the
mouth from the human microbiota database was discov-
ered. This intriguing finding related placental samples
derived from pregnant mothers. However, mouth micro-
biota samples were derived from a separate non-pregnant
female database and not the same pregnant mothers. This
requires additional studies wherein samples from different
sites in the same woman are analyzed. The fact that
E. coli was one of the largest taxa represented in the
placental samples is of interest in that this is a com-
mon resident of the intestine and thus suggests a
potential intestinal origin.
It is common dogma that the baby’s first stool (meco-
nium) is sterile. Studies demonstrating that meconium
from both preterm and term neonates frequently contain
cultivatable and non- cultivatable microbes refute this
notion [7,8,11,12]. The origin of these microbes is un-
known, but tenable support for the hypothesis that these
are derived from swallowed amniotic fluid has been bol-
stered by recent studies that show a high degree of simi-
larity between meconium microbes in those derived
from the literature to be found in amniotic fluid [7]. As
with the aforementioned placenta studies, this finding
also requires validation using multisite analysis from the
same pregnant woman.
Thus, the classic dogma that the newborn emerges from
a sterile environment should be considered a shortsighted
assumption. It is clear that the fetal immune system, espe-
cially that of the fetal intestine is rapidly evolving during
gestation and that postnatal morbidities such as necrotiz-
ing enterocolitis, chronic lung disease, brain white matter
disease and other inflammatory conditions are likely to be
affected by microbial colonization that occurs well before
the infant leaves the uterus (Figure 1).
One concept of in utero colonization has been that
microbes residing in the vagina ascend to the chorio-
decidual membranes, where they translocate into amni-
otic fluid [13,14]. One hypothesis suggests that an in-
flammatory response originating from the decidua leads
to preterm labor. Although this remains a commonly
held belief, studies suggest that inflammation in decidua
is not a cause of preterm labor, but rather is caused by
labor [15]. An alternative source of the inflammatory re-
sponse that has not been given much attention is the
fetus. The fetus is exposed to microbes through the fetal
skin, lungs, and gastrointestinal tract. Fetal gastrointes-
tinal tract exposure to these microbes appears to be of
particular interest because large quantities of amniotic
fluid are swallowed during the last stage of pregnancy
and thus expose the fetal intestine to these microbes[16,17]. The fact that the fetal intestine is a highly im-
munoreactive organ [18] that may elaborate an inflam-
matory response to these microbes, which in turn may
ultimately be responsible for triggering preterm labor is
intriguing and begs additional studies.
The site of entry of the microbes in the placenta, am-
niotic fluid and fetus remains unclear. However, a recent
study contradicts the notion that the microbes originat-
ing from the vagina are the origin of preterm labor [19].
Other potential hematogenous sources are the maternal
mouth via inflamed periodontal tissue and the maternal
intestinal tract [13]. If, in fact, the maternal intestine is
the origin of the microbes that are found in the fetus
and in the uterus, and if these indeed are related to in-
flammatory responses that originate in the fetus that
may induce preterm labor, this offers an exciting area for
interventions that include maternal dietary manipulation
and microbial therapeutic alterations by providing cer-
tain microbes into the mother’s diet [20] or perhaps even
very specific anti-microbial therapies that prevent those
microbes associated with preterm labor from thriving in
the maternal intestine and consequently the placenta,
amniotic fluid and the fetus.
In summary, pregnancy is the beginning of bacterial
exposure for the developing embryo and fetus. The origins
of these bacteria include the maternal gastrointestinal tract
and these bacteria have been isolated in umbilical cord
blood, amniotic fluid placenta, fetal membranes and meco-
nium. These microorganisms in many cases have been as-
sociated with no clinical evidence of infection in either the
mother or the fetus. One can speculate that the microbiota
to which the fetus is exposed may stimulate an inflam-
matory response, and depending on the types of mi-
crobes present, stimulate preterm labor. Furthermore,
these bacteria or their components may also contribute
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quent injury to the fetus and neonate [4,21] or even
immunologic tolerance [22] that leads to prevention of
certain diseases such as those associated with auto-
immunity and allergy in later life.Pre and perinatal factors affecting the developing
microbiome
Given that prenatal microbiota have profound effects
on the fetus and subsequent development, various
mechanisms of how these microbes relate to the host
remain an exciting area for research. Since this is such
a critical window for development, the interaction of
microbes with the host and with environmental per-
turbations such as maternal diet, antibiotics, and other
microbial exposures may play a highly significant role
(Table 1).
While it may be enlightening to determine the tax-
onomy of microbes present during this highly vulnerable
time, even more important is a better understanding of
the function of these microbes and their interaction with
the host. The microbial metabolites and immunologic
responses in mothers’ gastrointestinal tracts and genito-
urinary systems and mouth may have profound effects
on the fetus. Various metabolites such as short chain






















Indwelling feeding tubesplay a major role in determining subsequent phenotypes
when the fetus reaches later age.
Studies in both animals and humans are beginning to
support these notions. Autoimmune diseases such as
type I diabetes may be affected by such maternal envir-
onmental factors as type of diet and antibiotic treatment.
For example, a study in pregnant non-obese diabetic
(NOD) mice fed a gluten-free or standard diet until the
pups were weaned to a standard diet showed that the
early life gluten-free environment decrease the incidence
of diabetes and insulitis in the offspring [23]. This was
associated with differences in the intestinal microbiota
of the mothers who were fed the gluten-free diet. Of
interest is that pancreatic regulatory T cells were in-
creased in the gluten-free fed offspring as were tight
junction related genes in the intestine, which also corre-
sponded to decreased intestinal gene expression of pro-
inflammatory cytokines. Another study using the NOD
diabetic mouse model involved treatment of pregnant
mothers with a cocktail of antibiotics and investigation
of T lymphocyte populations in the offspring [24]. The
offspring from NOD mothers treated with antibiotics
during gestation showed a reduction in the diversity of
the gut microbiota, as would be expected. In addition,
the offspring of mothers treated with antibiotics also
showed immunologic alterations of the gut immune sys-
tem which potentially could become a risk factor for the
development of diabetes in these animals.
Cesarean section versus vaginal delivery also appears
to affect subsequent microbial colonization in the intes-
tine of the newborn and infant. A study by Dominguez
Bello [25] using 16SrRNA sequencing suggested that va-
ginally delivered infants acquired bacterial communities
resembling their own mother’s vaginal microbiota whereas
C-section infants were colonized by bacterial communities
similar to those found in the mother’s skin. Of interest is
that in this study the differences were seen in meconium,
the infants first stool, which would more likely represent
the in utero environment rather than whether the infant
passed through the birth canal or was born by cesarean
section. This raises the question of whether the mothers
need for a C-section versus vaginal delivery may have been
responsible for differences in the microbiota in these in-
fants, rather than the mode of delivery. Nevertheless, a
Canadian study evaluated fecal microbiota at four months
of age [26] in healthy infants who were born by either C-
section versus vaginal delivery. Differences were seen in
the fecal microbiota of infants born by C-section versus
vaginal delivery at the phylum level at four months after
birth. Further evaluation revealed that most of these
differences were seen in infants who were fed with for-
mula. Those infants receiving mothers’ milk exhibited
only minor differences at four months whether or not
they were born by C-section versus vaginal delivery. In
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Sweden [27], major differences in microbial diversity
were seen up to two years after birth in the fecal
microbiota of infants who had been delivered by
cesarean section versus vaginal delivery. There was a
preponderance of Bacteroidetes in the infants born by
vaginal delivery and this was seen in parallel to higher
levels of anti-inflammatory mediators in the same in-
fants who had the higher levels of Bacteroidetes. These
microbes are known to have in their cell walls a protein
which stimulates the production of these anti-inflammatory
mediators [28].
Since several epidemiologic studies suggest a greater
preponderance of autoimmune diseases, celiac disease,
obesity and other disorders in infants born by cesarean
section [29], this raises the question of whether increas-
ing levels of cesarean section may become a public
health issue in areas where C-sections are highly preva-
lent. This is especially important in some countries
where the prevalence of cesarean section has been ap-
proaching very high levels, up to 80%.
The preterm neonate
Enteral versus parenteral feeding
In neonatal intensive care, there has been a reluctance
to utilize the neonatal gastrointestinal tract for feeding
infants, largely because of the fear of necrotizing entero-
colitis (NEC) and also because many of these infants ex-
perience various levels of feeding intolerance. Instead,
these infants are nourished with intravenous parenteral
nutrition, which does provide nutrients to the rapidly
developing preterm infant, but is suboptimal in terms of
supporting intestinal mucosal growth and development.
At the same time that the infant gastrointestinal tract is
not being directly nourished with enteral feedings, mi-
crobes residing in the gastrointestinal tract of these in-
fants also are exposed to a lack of nutrients. This raises
the question of whether the lack of nutrient substrates
for microbes may affect microbial ecology and subsequent
interaction with the human host. It also raises the question
of whether these dietary perturbations may have an effect
on subsequent development of some of diseases seen in
preterm infants such as NEC, cholestatic liver disease,
chronic lung disease or brain white matter disease. Studies
in animals suggest that enteral nutrient deprivation
leads to a shift in intestinal microbiota to predomin-
antly gram negative Proteobacteria [30]. Along with this
is seen an increase in expression of pro-inflammatory
cytokines within the intestinal mucosa and loss of the
epithelial growth factors which decrease epithelial cell
proliferation and increase apoptosis [30]. Highly ger-
mane to this study in animals, is recent work done in
human infants by different research groups that show a
relationship of the Proteobacteria phylum of bacteria inthe intestine to the development of NEC in preterm in-
fants [31-33].
Antibiotics
The use of broad spectrum intravenous antibiotics in
very low birth weight infants shortly after birth is very
common. In fact, ampicillin and gentamicin are the two
most commonly used drugs in neonatal intensive care
[34]. Of interest is the fact that recent studies show that
the use of antibiotics as well as increased duration of
these antibiotics is associated with a greater likelihood of
the development of NEC and death [35,36]. The use of
antibiotics in these infants has been shown to alter the
intestinal microbial ecology [37,38]. The mechanisms of
how these alterations may alter host responses are not
yet clearly understood, but there are several possibilities.
The development of a dysbiosis after prolonged antibiotic
treatment may alter the commensal bacteria population
found at the surface of the intestine, such that these com-
mensal bacteria no longer provide colonization protection
from potential pathogens at the intestinal surface [39-41].
Pathogens can then interact with the intestinal surface in-
cluding the cells that underlie the epithelial layer that are
highly immunoreactive and may result in a brisk inflam-
matory response associated with inflammation related dis-
eases such as NEC, late onset sepsis as well as the distal
organ damage to the liver, lung and the brain.
Although antibiotic stewardship is becoming more
common in obstetrics and neonatal intensive care, we
still have a long way to go when it comes to overuse of
antibiotics. Despite benefits of antenatal antibiotics,
these are known to increase late onset neonatal infec-
tions [42]. Likewise, the notion that preterm delivery is
directly caused by pathogens that may affect the new-
born that can also be treated with early antibiotics has
never been fully evaluated. The use of early antibiotics in
the first days after birth is also correlated with increased
prevalence of late onset sepsis by potentially antimicro-
bial resistant and dangerous microbes such as Pseudo-
monas, Klebsiella and E. coli [43]. The fact that the
microbes can only be found in a small percentage, ap-
proximately 2%, [44] in the blood cultures of the babies
treated for presumptive sepsis in the immediate new-
born, suggests very strongly that there is over use of an-
tibiotics in this population. This is clearly an area that
requires further investigation and prompt attention.
Medications
The human premature neonate has been shown to have
low gastric acid output in the first weeks after birth.
Gastric acidity is known to be a major non-immune
defense mechanism against various infections. Preterm
infants have relatively low gastric acid production in the
first weeks after birth [45]. Many premature neonates
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Mostly these infants suffer from apneic and bradycardic
events, which are thought to be related to acid gastro-
esophageal reflux. Studies have shown that the relation-
ship between gastroesophageal reflux and apnea and
bradycardia is actually quite low, approaching approxi-
mately 3% [46]. These acid blockers have been shown to
increase the odds of development of NEC and have been
associated with increased death in these infants [47].
The precise mechanisms of how these affect the intes-
tinal micobiome is not well understood, but recent stud-
ies showing that Proteobacteria, the microbes that have
been associated with NEC, do not survive well in an
acidic environment [48]. Hence, removing this acidic en-
vironment may result in a better environment for these
bacteria to survive and result in pathogenesis. Along
with the data on H2 blockers being associated with
greater NEC, there is a small study that showed that
acidification of formula resulted in a lower incidence of
NEC in preterm infants [49]. Therefore routine use of
acid blockers in neonatal intensive care to prevent ap-
neas and bardycardias is not indicated.
Diet: formula versus human milk
There has been a long term concern about feeding pre-
term infants with their underdeveloped immune systems
human milk that may be colonized with microbes. Com-
mercial formulas are sterilized and do not contain mi-
crobes and donor human milk is pasteurized and should
contain few if any microbes. Recently, it has become
clear that human milk contains up to a wide variety of
taxa of microbes, many of which do not originate from
the skin of the mother or infant or the infant’s mouth
[50-52]. Instead, data suggests that many of these mi-
crobes originate from the mothers gastrointestinal tract
[52]. This is especially pertinent since manipulation of
the maternal microbiota by diet or microbial therapy
could be used to promote a breast milk microbial ecol-
ogy that is most conducive to infant health [20]. Labelled
microbes given to pregnant rodents have been found in
the mothers’ breast milk and subsequently in the infant
[53]. The exact mechanism of transfer to the mothers’
breast remains poorly understood but it has been specu-
lated that the intestinal tract during pregnancy is more
permeable than during the non-pregnant state and that
microbial translocation may occur readily through this
highly permeable intestine. Another mechanism involves
the transfer of microbes via dendritic cells which under-
lie the intestinal mucosa and can send their appendages
into the lumen of the intestine and subsequently enter
the bloodstream and present these cells to the mothers’
breast [52].
The possibility that these microbes actually play a role
in development of the infant intestinal microbiome hasbeen suggested [52] and is highly likely. Of interest is
that over time, the microbes from an individual mother’s
milk vary only slightly, but the microbes from an indi-
vidual mother appear to differ markedly from other
mothers [50]. This suggests that there may be a milk
microbiome that is specific for a certain mother infant
dyad and that this specificity could confer benefits to the
infant through an enteromammary system, which may
offer dynamic immunologic responses from the mother
to the newborn [54,55]. These would not be incurred by
infants receiving donor milk or formula or perhaps even
baby’s own mother’s milk that has been stored in a
freezer for prolonged periods. Along the same thinking
is the question of whether the technique of “kangaroo
care” or “mother skin to skin care” may also offer bene-
fits whereby the mother and infant are exposed to each
other’s microbes, and the mother acquires the infant’s
microbiota, which may offer specific benefits to the in-
fant immune system.
It is common practice to add fortifiers to either pre-
term baby’s own mother’s milk or donor milk. The effect
of these on the infant intestinal microbiome is poorly
understood. Of interest is that there is some literature
suggesting that fortifiers derived from human milk ra-
ther than bovine milk may be beneficial, [56] the relative
effects of these on the developing neonatal intestinal
microbiome have not been critically evaluated.
In summary, our concept of the newborn arising from
a sterile intrauterine environment and acquiring a
microbiome only after it emerges from the birth canal
should now be considered somewhat naïve. Large
quantities of potentially colonized amniotic fluid with
high immunologic and inflammatory potential pass
through the fetal intestinal tract. Prenatal exposure to
these microbes is likely to have major consequences.
These include a disposition to preterm labor, depend-
ing on which microbes are present and their func-
tional capability to incite inflammation. Factors that
affect this in-utero microbiome such as maternal anti-
biotics or maternal diet may play a large role in epi-
genetic and/or immunologic alterations that can occur
during this very critical window of development. Peri-
natal factors such as C-section or vaginal delivery may
have long term consequences via differential microbial
colonization of the fetus. Various factors in the new-
born such as antibiotic or other medication use, diet
(breast milk versus formula) or even direct close con-
tact between the mother infant dyad may be of critical
importance for future health of the infant. This is an
exciting area of current medical science that we are
fortunate enough to be a part of.Competing interests
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